Physician

Rene R Rubin, MD

According to 2025 Medicare claims, Rene Rubin, MD (NPI: 1285633016) practices hematology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is SATISH A SHAH MD PC (NPI: 1982734976; TIN: 23-2586060) and primary practice location at 19004-1017.

Rubin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 98,955 HCPCS/CPT codes, and received $2,631,931 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,859 prescription claims across 227 beneficiaries totaling $2,436,060 in drug costs, led by Lenvima (Lenvatinib Mesylate). DME data shows 22 claims. Open Payments data shows 157 records totaling $4,277. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,053,823 to $2,631,931. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,007 to $7,960.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	250	45,382	$1,053,823
2016	259	39,180	$1,008,382
2017	273	34,746	$901,991
2018	271	56,275	$1,504,365
2019	235	87,279	$2,159,072
2020	220	98,963	$2,242,841
2021	230	110,087	$1,882,042
2022	241	102,732	$1,732,633
2023	229	100,272	$2,139,392
2024	208	98,955	$2,631,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	273	2,408	$1,488,115
2016	255	2,428	$1,833,192
2017	231	2,102	$1,897,025
2018	233	1,932	$2,320,983
2019	219	2,256	$2,471,276
2020	273	2,734	$1,996,694
2021	272	2,812	$1,753,520
2022	247	2,374	$1,950,410
2023	242	1,906	$1,951,359
2024	227	1,859	$2,436,060

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	110	$55,296
2016	12	15	$2,087
2017	N/R	16	$1,866
2018	11	38	$2,180
2019	N/R	12	$685
2020	N/R	11	$283
2021	N/R	39	$2,309
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$1,993

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	929	$96
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	36	85	$51
96372	Injection of drug or substance under skin or into muscle	53	227	$12
36415	Insertion of needle into vein for collection of blood sample	183	840	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	178	829	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenvima	Lenvatinib Mesylate	21	630	$539,633
Lynparza	Olaparib	24	720	$405,368
Jakafi	Ruxolitinib Phosphate	12	360	$240,639
Verzenio	Abemaciclib	14	392	$219,990
Ibrance	Palbociclib	13	364	$205,318

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$1,365
B9002	Enteral nutrition infusion pump, any type	Y	N/R	11	$628

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$4,277	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rene R. Rubin, MD?

Tedicare shows public-source Medicare data for Rene R. Rubin, MD (NPI 1285633016), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rene R. Rubin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rene R. Rubin, MD?

Rene R. Rubin, MD is linked to SATISH A SHAH MD PC (billing NPI 1982734976) in the available physician profile data.

Does Rene R. Rubin, MD have Open Payments data?

Rene R. Rubin, MD has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.